X
ALKS icon

Xponance’s Alkermes ALKS Stock Holding History

Xponance’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$543K Sell
15,370
-463
-3% -$14.4K ﹤0.01% 982
2025
Q4 		$443K Buy
15,833
+127
+0.8% +$3.8K ﹤0.01% 1000
2025
Q3 		$471K Sell
15,706
-2,092
-12% -$59K ﹤0.01% 993
2025
Q2 		$509K Sell
17,798
-1,040
-6% -$31K ﹤0.01% 946
2025
Q1 		$622K Buy
18,838
+284
+2% +$9.26K 0.01% 866
2024
Q4 		$534K Buy
18,554
+976
+6% +$28.1K ﹤0.01% 933
2024
Q3 		$492K Buy
17,578
+884
+5% +$23.6K ﹤0.01% 939
2024
Q2 		$402K Sell
16,694
-261
-2% -$6.4K ﹤0.01% 972
2024
Q1 		$459K Buy
16,955
+70
+0.4% +$1.99K ﹤0.01% 968
2023
Q4 		$468K Sell
16,885
-142
-0.8% -$3.69K 0.01% 954
2023
Q3 		$477K Buy
17,027
+322
+2% +$9.44K 0.01% 906
2023
Q2 		$523K Buy
16,705
+6,453
+63% +$195K 0.01% 893
2023
Q1 		$289K Buy
10,252
+88
+0.9% +$2.4K ﹤0.01% 1049
2022
Q4 		$266K Buy
10,164
+427
+4% +$10.2K ﹤0.01% 1060
2022
Q3 		$217K Buy
9,737
+711
+8% +$18.5K ﹤0.01% 1073
2022
Q2 		$269K Buy
9,026
+1,198
+15% +$34.4K 0.01% 1034
2022
Q1 		$206K Buy
+7,828
New +$194K ﹤0.01% 1104
2021
Q4 		– Sell
-8,217
Closed -$253K – 1173
2021
Q3 		$253K Sell
8,217
-788
-9% -$22.3K ﹤0.01% 1080
2021
Q2 		$221K Buy
+9,005
New +$200K ﹤0.01% 1149

Other funds holding ALKS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Xponance's ALKS Position: Q1 2026 in Review

Xponance reduced its Alkermes (ALKS) stake by 2.9% in Q1 2026, selling an estimated $14.4K and leaving 15,370 shares worth $543K. The position accounts for ﹤0.01% of the portfolio, ranked #982.

Xponance first reported a position in ALKS in Q2 2021 and has held it in 19 quarters since. The position peaked at $622K in Q1 2025. 388 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • Xponance held 15,370 shares of Alkermes worth $543K as of Q1 2026.
  • Xponance sold 463 Alkermes shares in Q1 2026, an estimated $14.4K.
  • Alkermes made up ﹤0.01% of Xponance's portfolio in Q1 2026, its #982 holding.
  • Xponance first reported a position in Alkermes in Q2 2021 and has held it in 19 quarters since.
  • Xponance's Alkermes position peaked at $622K in Q1 2025.
  • 388 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.